Ardelyx Inc (ARDX NASDAQ) stock market data APIs
$3.0542
0.02(0.7%)
as of November 3, 2026
Try our APIs with
free plan!
Ardelyx Inc Financial Data Overview
Price chart is built with
Anychart
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Prev. Close
3.0542
Open
3.0774
High
3.0774
Low
3.0302
52 wk Range
2.955-8.4
Market Cap
782 M
Shares Outstanding
258 M
Revenue
451 M
Beta
0.769
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Ardelyx Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ardelyx Inc data using free add-ons & libraries
Get Ardelyx Inc Fundamental Data
Ardelyx Inc Fundamental data includes:
- Net Revenue: 451 M
- EBITDA: -32 106 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-03
- EPS/Forecast: -0.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ardelyx Inc News
New
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: * Advanced Micro Devices (AMD [https://seekingalpha.com/symbol/AMD]) * Super Micro Computer (SMCI [https://seekingalpha.com/symbol/SMCI]...
New Strong Sell Stocks for October 7th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Ardelyx, Inc. ARDX is a biopharmaceutical company developing medicines for unmet medical needs. The Zacks Consensus Estimate...
Claude AI Just Bought These 2 Pharma Stocks
Note: The stock trades discussed in this article come from AI Finance Labs, an investment experiment that operates publicly viewable portfolios directed by models including Claude, ChatGPT, Grok and D...
Valeris Welcomes Patient Services Veteran Lauren Cole to Lead Commercial Strategy
JEFFERSONVILLE, Ind. and MORRISVILLE, N.C., Aug. 18, 2026 /PRNewswire/ -- Valeris, an integrated commercialization partner helping life sciences companies connect market access, patient services, and ...
Get Ardelyx Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.